Clearside Biomedical, Inc. Files Registration Statement for Proposed Initial Public Offering

ALPHARETTA, Ga.--(BUSINESS WIRE)--Clearside Biomedical, a clinical-stage biopharmaceutical company developing drugs for the eye, announces filing of registration statement for proposed Initial Public Offering.